0.68 - 0.75
0.33 - 0.86
13.06M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.40%
Negative revenue growth while 0360.HK stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-37.16%
Negative gross profit growth while 0360.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-160.18%
Negative EBIT growth while 0360.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-160.18%
Negative operating income growth while 0360.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-2470.86%
Negative net income growth while 0360.HK stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2340.00%
Negative EPS growth while 0360.HK is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2611.11%
Negative diluted EPS growth while 0360.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
8.64%
Share change of 8.64% while 0360.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-0.01%
Reduced diluted shares while 0360.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-3.94%
Dividend reduction while 0360.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
6.72%
OCF growth of 6.72% while 0360.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
8.02%
FCF growth of 8.02% while 0360.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-50.96%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-59.12%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-37.20%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-369.96%
Negative 10Y OCF/share CAGR while 0360.HK stands at 331.52%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
8.30%
Below 50% of 0360.HK's 428.72%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
36.01%
3Y OCF/share CAGR under 50% of 0360.HK's 249.89%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-175.70%
Negative 10Y net income/share CAGR while 0360.HK is at 98.99%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-159.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1528.07%
Negative 3Y CAGR while 0360.HK is 52.64%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.91%
Positive growth while 0360.HK is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
-16.92%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-22.64%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
64.08%
Dividend/share CAGR of 64.08% while 0360.HK is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-75.82%
Negative 5Y dividend/share CAGR while 0360.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-33.71%
Negative near-term dividend growth while 0360.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
1.80%
Our AR growth while 0360.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-26.93%
Inventory is declining while 0360.HK stands at 5.37%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
11.24%
Asset growth above 1.5x 0360.HK's 0.15%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-11.94%
We have a declining book value while 0360.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
77.55%
Debt growth far above 0360.HK's 1.55%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-34.23%
Our R&D shrinks while 0360.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.18%
We cut SG&A while 0360.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.